Literature DB >> 9850660

FNAC guided by computed tomography in the diagnosis of primary pancreatic adenosquamous carcinoma. A report of three cases.

M D Lozano1, A Panizo, I J Sola, F J Pardo-Mindán.   

Abstract

BACKGROUND: Pancreatic adenosquamous carcinoma (ASqC) is an unusual histologic subtype of nonendocrine neoplasia of the pancreas. Although fine needle aspiration cytology (FNAC) is now accepted as a reliable procedure for the diagnosis of pancreatic malignancies, many of these unusual tumors are still diagnosed after surgery or at necropsy. CASES: Between January 1995 and July 1996, 3 of 35 primary pancreatic malignant tumors were diagnosed as ASqC based on computed tomography-guided FNAC. After cytologic diagnosis, all three patients were treated with neoadjuvant chemotherapy and radiotherapy. Two patients completed the treatment and underwent a surgical pancreatic-duodenectomy with antrectomy. The remaining patient is currently under treatment. That patient had a highly infiltrative pancreatic mass that affected the muscular small bowel wall. An endoscopic biopsy was performed. The cytologic diagnosis was confirmed by histology in all cases. Immunohistochemically both components, squamous and glandular, showed reactivity for several keratins, while only the glandular pattern was reactive with carcinoembryonic antigen (CEA).
CONCLUSION: FNAC is an accurate, rapid and sensitive tool in the diagnosis of ASqC of the pancreas. We recommend a careful search for both malignant components. Immunoreactivity for CEA can be of help in the detection of the glandular component of this tumor.

Entities:  

Mesh:

Year:  1998        PMID: 9850660     DOI: 10.1159/000332185

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  6 in total

Review 1.  Surgical outcome of adenosquamous carcinoma of the pancreas.

Authors:  Takehiro Okabayashi; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 2.  Adenosquamous carcinoma of the pancreas: successful treatment with extended radical surgery, intraoperative radiation therapy, and locoregional chemotherapy.

Authors:  H Yamaue; H Tanimura; H Onishi; M Tani; H Kinoshita; M Kawai; S Yokoyama; K Uchiyama
Journal:  Int J Pancreatol       Date:  2001

Review 3.  Clinicopathological features of adenosquamous pancreatic cancer.

Authors:  Paolo Regi; Giovanni Butturini; Giuseppe Malleo; Federica Pedica; Mirko D'Onofrio; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2010-07-09       Impact factor: 3.445

4.  The role of preoperative biopsy in pancreatic cancer.

Authors:  D L Clarke; B A Clarke; S R Thomson; O J Garden; N G Lazarus
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

5.  Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients.

Authors:  K Ranh Voong; Jon Davison; Timothy M Pawlik; Manuel O Uy; Charles C Hsu; Jordan Winter; Ralph H Hruban; Daniel Laheru; Sonali Rudra; Michael J Swartz; Hari Nathan; Barish H Edil; Richard Schulick; John L Cameron; Christopher L Wolfgang; Joseph M Herman
Journal:  Hum Pathol       Date:  2009-10-03       Impact factor: 3.466

6.  Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis.

Authors:  Matthew Harold G Katz; Thomas H Taylor; Waddah B Al-Refaie; Mark H Hanna; David K Imagawa; Hoda Anton-Culver; Jason A Zell
Journal:  J Gastrointest Surg       Date:  2010-11-17       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.